Semi Equipment Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Semi Equipment Analysis

SOXX 312.18

-0.2%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Sr K	3/13/2023 12:42:56 AM
	of 95536

Carl Icahn Carl Icahn Prepares for Proxy Fight at Illumina Billionaire activist seeks three seats on biotech’s board Illumina was revered for its DNA-sequencing capabilities and was valued at more than $70 billion in summer 2021.PHOTO: ILLUMINA INC/VIA REUTERS By Lauren Thomas and Cara Lombardo Updated March 12, 2023 10:50 pm ET SHARE Listen to article (2 minutes) Carl Icahn is preparing a proxy fight at Illumina Inc., arguing the biotechnology company cost its shareholders roughly $50 billion by plowing ahead with a risky acquisition despite opposition from regulators. The billionaire activist plans to nominate three people to the San Diego company’s board, according to a letter Mr. Icahn plans to send to Illumina’s shareholders Monday that was viewed by The Wall Street Journal. Exc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next